Afib patients with sleep apnea have an increased incidence of non-PV triggers. Ablation of atrial substrate including those non-PV triggers was associated with substantially improved arrhythmia-free survival when compared with OSA patients undergoing PVI alone.1

Sleep Apnea Affects Half of All Patients with Cardiovascular Disease.

Sleep apnea puts an enormous strain on the heart and remodels the cardiac substrate through stretching, oxidative stress and frequent sympathetic surges.4

92 Million Patients in the US Have Cardiovascular Disease2

50% Also Suffer From Sleep Apnea3

80% Remain Undiagnosed3

AHA recommends that screening for sleep apnea risk should be integrated into routine clinical care7

A simple yes/no questionnaire called STOP-BANG takes just a few minutes and indicates a high probability of obstructive sleep apnea and supports the required documentation for Medicare and commercial insurance payers.5-6

Total Sleep Solutions

Total Sleep Solutions with WatchPAT is a Comprehensive Sleep Apnea Management Program Designed to Optimize Patient Outcomes. It expands the reach of sleep services by enabling point of care flexibility in the cardiology office and provides scalable acquisition models to diagnose cardiac patients suffering from sleep apnea. apnea. treatment compliance.

More than 50% of cardiovascular patients remain undiagnosed or treated for sleep apnea. A simple questionnaire can help you identify patients who may be at risk for sleep apnea, making them eligible for a diagnostic sleep test.
Click Here
To be eligible for insurance coverage for sleep apnea therapy, your patients need a validated diagnosis. Diagnosis is obtained with an easy to use sleep study, performed at the patient’s home.
Click Here
Adequately treated sleep apnea has been associated with improved cardiovascular outcomes and lower rates of hospital readmission.
Click Here
The success of sleep apnea therapy depends on patients’ compliance. Compliance to therapy should be optimized to improve cardiovascular outcomes. Your patients will benefit from your staying informed and updated on their progress.
Click Here

First and Only Disposable HSAT

- No Return Shipment
- No Cleaning or Charging
- Immediate Access to Sleep Data for Interpretation
- Central Sleep Apnea Identification
Learn More

Simple. Accurate. Reliable.

- Intuitive Design for Improved Patient Comfort
- Improved Workflow with One Stop Processing
- 15 Second Rapid Data Download
- Central Sleep Apnea Identification
Learn More

Like to Know More? Fill Out This Form and We'll Contact You.

WatchPAT Blue RGB
Itamar - Right

*Your information will be handled according to our Privacy Policy.

References

  1. Anter et al. Circulation: Arrhythmia and Electrophysiology. 10(11):e005407, NOV 2017
  2. Heart Disease and Stroke Statistics 2017 At-a-Glance
  3. Sleep Apnea and Cardiovascular Disease, JACC Vol. 52, No. 8, 2008, August 19, 2008:686-717 Wharton, R. (2017, May 30) Wide Screening of Obstructive Sleep Apnea in a Cardiology Clinic
  4. Anter E. Circulation: Arrhythmia and Electrophysiology. 2017, Atrial Substrate and Triggers of Paroxysmal Atrial Fibrillation in Patients with Obstructive Sleep Apnea
  5. Shulka, A (2015, February 12) Effect of OSA treatment on Atrial Fibrillation Recurrence
  6. Neilan et al, JAHA, 2013 Effect of Sleep Apnea and Continuous Positive Airway Pressure on Cardiac Structure and Recurrence of Atrial Fibrillation
  7. Circulation. November 2016, Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health